Since launching as a spin-out from the University of Oxford, Brainomix has pioneered the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions.
Our Brainomix 360 Stroke platform is the world's most comprehensive stroke imaging solution, widely adopted across multiple healthcare systems worldwide.
Building on this legacy and success, we are expanding beyond stroke into new areas, where there are similar unmet needs and opportunities to improve diagnosis and treatment.